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Background and Aim: Tuberous sclerosis complex (TSC) is associated with a high rate
of attention deficit-hyperactivity disorder (ADHD), usually with more severe symptoms
than in idiopathic cases. Event-related potentials have been used in idiopathic ADHD,
and they have been proposed as a possible biomarker of symptoms severity. Aim of
this study was to investigate event-related potential (ERP) characteristics in patients with
ADHD secondary to TSC, compared to patients with drug-naive idiopathic ADHD and
healthy controls (HCs), to investigate whether (1) distinct clinical features can be due
to different pathophysiological mechanisms, and (2) ERPs may reliably predict ADHD
symptoms severity in TSC.
Materials and Methods: We enrolled 13 patients with idiopathic ADHD (iADHD), 6
patients with ADHD associated with TSC (tscADHD), and 14 age-matched HCs (7–17
years). All of them underwent ERP recording, with mismatch negativity (MMN) preceding
the P300 recording. All patients underwent neurocognitive evaluations.
Results: Mismatch negativity latency was shorter in iADHD (P = 0.04) and tscADHD
(P = 0.06) than in HC, with no difference between patients’ groups. Mismatch negativity
amplitude was significantly higher in patients (both iADHD and tscADHD) than in HC. The
P300 amplitude was significantly lower in iADHD patients than in both tscADHD patients
(P = 0.03) and HCs (P < 0.001). No difference was found between tscADHD patients
and HCs (P = 0.2).
Conclusion: While patients with iADHD present lower P300 amplitude than HC, in
tscADHD patients P300 amplitude was not different from that in HC, suggesting that
in TSC P300 amplitude does not really reflect symptom severity.
Keywords: tuberous sclerosis complex, ADHD, ERP, MMN, P300, attention
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INTRODUCTION
Tuberous sclerosis complex (TSC) is an autosomal dominant
multisystem disease characterized by hamartomas in several
organs and systems (1). Central nervous system involvement
represents the main source of morbidity for patients affected
by this complex disease and includes epilepsy and a variety of
neuropsychiatric disorders (2). Attention-deficit hyperactivity
disorder (ADHD) is a neuropsychiatric condition highly
prevalent in the general population (3%−7%) (3, 4), but with
a significantly higher ratio in patients with TSC, affecting
∼30–50% of patients (2). Attention-deficit hyperactivity disorder
is characterized by inattention, hyperactivity, and impulsive
behavior (5)Core symptoms of ADHD include specific deficits
in executive functions, including inhibition, and in attentional
processes such as vigilance, sustained, divided, and selective
attention (6). Attention-deficit hyperactivity disorder occurs
in up to 50% of patients with TSC, being 10 times more
prevalent in TSC than in the general population (7). Despite this
frequent association, the real pathophysiological mechanisms
underlying this comorbidity are not completely understood,
but cortical tubers, frontal epileptiform abnormalities, and
the genetic mutation per se are believed to play a role (2, 8).
In TSC, ADHD often co-occurs with other neuropsychiatric
disorders, including intellectual disability and autism spectrum
disorder (7). Clinical experience suggests that symptoms
of ADHD in children with TSC are usually more severe
and tend to present lower benefits to pharmacological
and non-pharmacological treatments when compared to
idiopathic ADHD.
Attention and inhibition, which are core aspects in ADHD,
can be studied with neurophysiological techniques, including
event-related potentials (ERPs), which in the last decades have
been widely used in this population, revealing abnormalities in
the attention-dependent processing (9). The P300 component
is an endogenous positive potential peaking 300ms after a
stimulus and generated by several cortical and subcortical
structures (10, 11). It is believed to reflect executive and
attentional function, including the updating of working
memory, event categorization, and attentional resource
allocation, as well as attentional reorientation (12). Moreover,
P300 has been proposed to reflect late-stage monitoring of
outcomes related to inhibitory processes (13). Therefore,
its amplitude seems to be related with the allocation of
attentional resources, whereas the latency reflects the stimulus
evaluation time (14). Mismatch negativity (MMN) is an ERP
component occurring ∼100–200ms after the onset of a deviant
stimulus, therefore before P300 (15), and it represents an
automatic cerebral discrimination process, not under attentive
control (16).
Different reports suggest that children with ADHD present
lower amplitude and higher latency P300 (17), so that some
authors proposed to use this ERP component as a marker of
disease severity (18). The available data concerning MMN are
more conflicting with different studies failing to find statistically
significant differences between children with ADHD and
healthy subjects (19). Event-related potential components can
be modified by ADHD pharmacotherapies, such as atomoxetine
and methylphenidate, which increase the P300 (20) and MMN
(21) amplitudes.
The aim of this study was to investigate ERP characteristics
in patients with ADHD secondary to TSC, compared to patients
with drug-naive idiopathic ADHD and healthy controls (HCs),
to investigate whether distinct clinical features can be due to
different pathophysiological mechanisms.
MATERIALS AND METHODS
Participants
We enrolled patients with idiopathic ADHD (iADHD) and
with ADHD associated with TSC (tscADHD), and age-matched
HCs. Inclusion criteria for patients with ADHD (with or
without TSC) were diagnosis of ADHD according to the
Diagnostic and Statistical Manual of Mental Disorders, Fifth
Edition (DSM-5) criteria and age 7–17 years. Moreover, iADHD
patients did not have to present any other neurological or
medical condition associated with ADHD. Exclusion criteria
were cognitive impairment (intelligence quotient <70),
psychiatric comorbidity, and sensory deficits that could interfere
with behavioral performances or with electrophysiological
results. If ADHD was pharmacologically treated, children
were asked to withdraw medications for 48 h before the
neurophysiological and neuropsychological examination.
Healthy controls were children and adolescents without a
history of neurological or neuropsychiatric conditions. All
patients and healthy subjects had had a normal audiological
evaluation before the study. All participants’ caregivers signed
an informed consent form. The study was approved by the local
ethical board.
ERP Recording and Analysis
For ERP recording, subjects were comfortably seated in a
quiet room. Mismatch negativity recording preceded the P300
recording in all our children and adolescents.
Auditory stimuli were sinusoidal tones (10-ms duration, 2-
ms rise and 2-ms fall time, 85-dB SPL of intensity), presented
binaurally via headphones. Frequent 750-Hz tones and deviant
500-Hz tones were delivered with a probability of 85 and 15%,
respectively. A fixed interstimulus interval (ISI) of 1 s and an ISI
variable between 0.8 and 1.2 s were used for MMN and P300
recording, respectively.
Event-related potentials were recorded from three scalp
electrodes, located at Fz, Cz, and Pz positions of the 10–
20 International System. A further electrode placed in the
outer cantus of the right eye recorded the electro-oculogram
(EOG). Reference was at the nose. Electroencephalogram (EEG)
sampling rate was of 1,024Hz, and the analysis time was
1,000ms, including 100ms of prestimulus delay. The amplifier
bandpass was 0.1 to 30Hz (24-dB roll-off). An automatic artifact-
rejection system excluded from the average all runs containing
transients exceeding ± 150 µV at any recording channel,
including the EOG. Averages of 15 trials (deviant stimuli) were
used for ERP measurements.
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MMN Recording
Mismatch negativity was recorded after 100 acoustic stimuli.
Children were instructed to read a novel; thus, they did not
pay attention to the acoustic stimulation. They were required to
summarize the novel in a short briefing following the stimulation.
P300 Recording
Children underwent a block of∼100 acoustic stimuli. They were
instructed to count the number of infrequent tones mentally.
No motor response was required. Averages in which counting
mistake had exceeded 10% would not have been considered in
the data analysis.
ERP Analysis
The N1 and P2 latencies and the peak-to-peak N2/P2 amplitude
were measured in the Cz traces recorded to deviant stimuli. For
MMN labeling, difference traces, obtained by subtracting the
frequent stimuli from deviant stimuli traces, were calculated. In
Fz difference trace, MMN latency and amplitude were measured
at the peak and from the baseline, respectively. P300 latency and
amplitude were measured in the Pz trace to deviant stimuli at the
peak and from the baseline, respectively.
Cognitive and Neuropsychological
Examination
All patients underwent the administration of an extensive
battery of tests for the assessment of cognitive functioning
and neuropsychological phenotype. This battery included the
following tests: (1) Wechsler Intelligence Scale for Children
for the determination of the intelligence quotient; (2) Tower
of London test for the assessment of planning and problem
solving skills and cognitive flexibility; (3) span of forward and
backwardmemory numbers (DSF andDSB) for themeasurement
of short-term verbal memory and working memory; (4) Trail-
Making Test Part A and Part B for the evaluation of visual
search strategies, selective and divided attention; (5) phonological
(FAS) and semantic (CAT) verbal fluency test for the evaluation
of verbal ability to access vocabulary by phonological and
semantic means; (6) Subtest ToM and ER of the NEPSY-II
battery to assess the ability to recognize one’s own and others’
mental states and the ability to recognize facial expressions; (7)
Physical and Neurological Assessment of Subtle Signs to evaluate
minor neurological signs; (8) Schedule for Affective Disorders
and Schizophrenia for School-Aged Children—Present and
Lifetime Version, a psychodiagnostic tool for the assessment
of psychopathological symptoms in children and adolescents
according to DSM-IV Text Revision criteria; (9) Conners’ Parents
and Teachers Rating Scale–Revised, questionnaires to be filled
in by parents and/or teachers, used for the evaluation of
ADHD from 3 to 17 years, and for externalizing disorders
that can be found in comorbidities; they also provide an index
(ADHD Index), which is able to differentiate subjects affected
by unaffected; (10) Child Behavior Checklist for Ages 6–18,
questionnaire to be filled in by parents, which assesses the
presence of internalizing and externalizing symptoms in children
and adolescents aged between 6 and 18 years.
Statistical Analysis
Neurophysiological Results
Mismatch negativity and P300 latencies and amplitudes were
compared by means of one-way analysis of variance (ANOVA),
by considering the group of subjects (iADHD, tscADHD, and
HC) as the variable. Significant values underwent post hoc
Bonferroni test. Moreover, because of the low number of
tscADHD patients, as compared to iADHD patients and healthy
subjects, we performed also a single-case analysis by considering
patients falling within or out of a 95% confidence level interval of
any ERP parameter, calculated from healthy subjects.
Neuropsychological Results
The scores obtained at the different tests were compared
between iADHD and tscADHD patients by means of unpaired
Student t-test.
Correlation Analysis
In our patients, we investigated whether there was a correlation
between the ERP data and the neuropsychological results.
A series of correlation analyses between the latencies and
amplitudes of both the MMN and the P300 potentials and
the different neuropsychological scores was performed. Pearson
coefficients were computed.
The statistical significance was fixed at P < 0.05.
RESULTS
Demographics
We enrolled 6 patients (3 females, 6 males) with ADHD
secondary to TSC, aged 8–15 years (mean = 12.6 years, median
= 15 years), and 13 patients (4 females, 9 males) with idiopathic
ADHD, aged 7 to 16 years (mean = 10.4 years, median = 9
years). We also included in the study 14 HCs (9 females, 5 males)
aged 8 to 16 years (mean = 11.9 years, median = 12.5 years).
No difference in age was found between the groups of subjects
(one-way ANOVA: F = 0.57, P = 0.57).
Clinical, Neurophysiological, and
Neuroimaging Data
In patients with tscADHD, we also collected additional clinical
information. None of them presented with active clinical seizures
at the moment of the study, and only one of them was
under antiepileptic treatment (carbamazepine), with the last
epileptic seizure ∼2 years before the study enrolment. All but
one presented a normal EEG; the only patient with abnormal
EEG presented sporadic epileptiform bilateral temporo-occipital
abnormalities. All six tscADHD patients presented typical brain
magnetic resonance imaging patterns with cortico/subcortical
tubers, in all brain areas, including frontal and temporal lobes.
None of them presented large, dysplastic, or cystic lesions. None
of the patients presented brainstem lesions. They all presented
white matter migration lines and subependymal nodules.
Subependymal giant cell tumor was present in one patient.
Table 1 summarizes main clinical, EEG, and neuroimaging data
of tscADHD patients.
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TABLE 1 | Clinical, EEG, and neuroimaging characteristics of tscADHD patients
enrolled in the study.
Patient Active
epilepsy
AED
treatment
IED Brain MRI
Tubers RML SEN SEGA
1 No No No Yes,
diffuse
Yes,
diffuse
Yes No
2 No No No Yes,
diffuse
Yes,
diffuse
Yes No
3 No No No Yes,
diffuse
Yes,
diffuse
Yes No
4 No No Yes,
bilateral
TO
Yes,
diffuse
Yes,
diffuse
Yes No
5 No No No Yes,
diffuse
Yes,
diffuse
Yes No
6 No CBZ No Yes,
diffuse
Yes,
diffuse
Yes Yes
*Active epilepsy means epileptic seizures in the last 2 years. AED, antiepileptic drugs;
IED, interictal epileptiform discharges; RML, radial migration lines; SEN, subependymal
nodules; SEGA, subependymal giant cell astrocytomas; MRI, magnetic resonance
imaging; CBZ, carbamazepine; TO, temporo-occipital.
ERP Results
Event-related potential values are shown in Table 2. N1 (F =
1.1, P = 0.34) and P2 (F = 1.22, P = 0.31) latencies and
N1/P2 amplitude (F = 0.13, P = 0.88) were not different
between groups.
Analysis of variance showed a significant effect of the group
on both MMN latency (F = 7.5, P = 0.01) and amplitude (F
= 3.2, P = 0.0001). Post hoc analysis showed that the MMN
latency was shorter in patients than in HC, and this difference
was significant for iADHD patients (P = 0.04) and marginally
significant for tscADHD patients (P = 0.06). No difference
was found between patients’ groups (P = 0.3). As for the
MMN amplitude, it was significantly higher in patients than
in HCs (P < 0.01). No difference was found between patients’
groups (P = 0.32).
One-way ANOVA showed a significant effect of the group
on the P300 amplitude (F = 13.7, P < 0.001). Post hoc analysis
showed the P300 amplitude was significantly lower in iADHD
patients than in both tscADHD patients (P = 0.03) and HCs (P
< 0.001). No difference was found between tscADHD patients
and HCs (P = 0.2). As for the P300 latency, the ANOVA showed
a global effect of the group (F = 4.3, P = 0.02), but the post hoc
analysis did not show any significant difference.
Table 3 shows a single case analysis for any considered ERP
value. This confirms what was found with the ANOVA.
Figure 1 shows P300 and MMN of one patient with iADHD
compared with a patient with tscADHD and a control subject.
Cognitive and Neuropsychological Results
Cognition
The average intellectual quotient (IQ) values were overall lower
in tscADHD than in iADHDpatients, with statistically significant
differences in all the quotients, so total IQ (105.9 ± 10.2 vs. 85.8
TABLE 2 | Event-related potential amplitudes and latencies in all subjects enrolled
in the study.
N1
latency
(ms)
P2
latency
(ms)
N1/P2
amplitude
(µV)
MMN
latency
(ms)
MMN
amplitude
(µV)
P300
latency
(ms)
P300
amplitude
(µV)
iADHD patients
1 109 141 16.9 112.6 10.5 299.8 9.2
2 112.1 165.5 8.7 120.9 4 301.5 5.6
3 108 141.3 11.3 141.1 6.7 330.8 2.2
4 90.8 151.4 10.9 103.5 3.3 319.8 3.7
5 109.1 167.2 13.5 109.1 20.3 327.4 6.5
6 97.9 127 16.9 97.9 7.5 319.1 13
7 109 141.4 13.6 125 33.9 349.1 3.5
8 109.6 159.2 22.6 109.6 12.8 363.3 2.7
9 106.7 139.4 7.8 106.7 6.8 279.3 9.3
10 109 141.3 15.8 148.9 15.4 298.1 9.78
11 117.2 136 13.4 127.9 20.9 325.4 11.5
12 110.4 152.6 14.3 114.5 13 295.9 12.3
13 95 123 10.2 95 5.3 312 5.5
Mean 106 145.1 13.5 116.4 12.3 317 7.3
Standard
deviation
7.4 13.5 4 16 8.7 23 3.8
tscADHD patients
1 110.4 145.8 9.2 91.6 4.8 340.1 5.2
2 109 140.3 13.9 105.8 18.2 383.1 26.3
3 108.9 158.7 15.7 143.3 15 264.2 20.2
4 74.7 94.7 18 74.7 11 249.5 18.7
5 115 135.7 14 115 45.4 312.7 7.5
6 104 166.8 12.7 104 14.8 324.2 7
Mean 103.7 140.3 13.9 105.7 18.2 312.3 14.2
Standard
deviation
14.6 25.2 3 23.1 14.1 49.4 8.7
Healthy subjects
1 79.9 132 7.6 99.3 5.8 360.3 30.9
2 119.1 148.2 17.1 99 9.8 415 31.3
3 108 174.5 17.1 160 5 317 22.3
4 101 145 11.4 154.7 5 373.8 30.4
5 102 156.5 9.5 168 3.8 276 15.3
6 101.2 122.2 19.3 152 4.5 235 8.9
7 86 180.8 12.2 132.2 3 386 23.4
8 98.8 148 13.3 140 4.4 301.7 7.5
9 124 172.4 17.4 136 5.8 388 9
10 95 132.6 8 60 4.8 401 20
11 95 165.5 16.8 132 1.9 378.5 14.7
12 109 148.6 8 167 10.1 320 13
13 101.1 127 14.7 161.8 6.8 552 17.8
14 95 141.6 13.2 158 3.9 353.2 27.8
Mean 101.1 149.6 13.3 137.1 5.3 361.3 19.5
Standard
deviation
11.6 18.3 4 31.4 2.3 75.0 8.5
Means and standard deviations in each group of subjects are also shown.
± 16.4; P = 0.004), verbal IQ (113.9 ± 15.2 vs. 92.2 ± 15.9; P =
0.016), and performance IQ (109.1 ± 15.6 vs. 91.3 ± 12.2; P =
0.032) (Table 4).
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Neuropsychological Data
Performances in executive functions were globally lower
in subjects with tscADHD than in iADHD patients, with
statistically significant differences both in direct number span
(DSF) (P = 0.006) and in categorical fluency (CAT) (P
TABLE 3 | The 95% confidence level intervals for the different ERP parameters.
95% confidence level interval* iADHD tscADHD
In Out In Out
N1 latency 91.4–110.7ms 10 3 4 2
P2 latency 135–164.6ms 9 4 4 2
MMN latency 115.8–158.4 ms 5 8 1 5
P300 latency 310.5–411.8ms 8 5 4 2
N1/P2 amplitude 10–16.5 µV 8 5 4 2
MMN amplitude 3.8–6.9 µV 4 9 1 5
P300 amplitude 13.7–25.2 µV 0 13 2 4
The numbers of both iADHD and tscADHD patients falling within (IN) or out of (Out) each
interval are indicated.
*Calculated from values recorded in healthy subjects.
Bold characters indicate the significant differences found with the analysis of
variance (ANOVA).
= 0.018). Although tscADHD children performed worse
in all the other administered tests, no other statistical
differences have been detected. Table 5 summarizes the results of
neuropsychological assessments.
Correlation Analysis
We found one significant positive correlation between the
P300 amplitude and total IQ score in iADHD patients
(R2 = 0.35, P = 0.03). It means that in this group of
patients the larger was the P300 amplitude, the higher
was the total IQ (Figure 2). It is noteworthy that the
same correlation was not found in tscADHD patients
(R2 = 0.004, P = 0.9). No other significant correlations
were obtained.
TABLE 4 | Mean values of total (TIQ), verbal (VIQ), and performance (PIQ)
intelligent quotient in patients with idiopathic ADHD compared to patients to
ADHD associated with TSC.
iADHD tscADHD P
TIQ 105.9 85.8 0.004
VIQ 113.9 92.2 0.016
PIQ 109.1 91.3 0.032
FIGURE 1 | The figure shows MMN (left) and P300 (right) recording in a patient with iADHD (upper), tscADHD (middle), and a control subject (lower). For MMN
recording, the Fz traces are shown, whereas for P300 recording the traces are obtained from the Pz electrode. Recordings to frequent and deviant stimuli are in black
and red color, respectively, whereas for MMN recording, the green curves are calculated by subtracting traces to frequent stimuli from those to deviant stimuli.
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DISCUSSION
To the best of our knowledge, this is the first study
comparing neurophysiological and neuropsychological tests
between patients with iADHD and tscADHD. The main
difference between the groups of patients concerned the P300
amplitude, which was lower in iADHD but not in tscADHD
patients, as compared to HC. This difference allows us to
speculate about the psychophysiological meaning of the P300
amplitude in different clinical contexts.
P300 Amplitude in ADHD May Depend on
the Etiology
That patients with idiopathic ADHD present a significantly
lower P300 amplitude than HCs, which appears to be in
TABLE 5 | Mean values of the results obtained in neuropsychological tests
administered in subjects with idiopathic ADHD and ADHD with TSC.
iADHD tscADHD P
ToL (z) −0.7 −1.22 0.08
DSF −0.43 −2.15 0.006
DSB −0.05 −1.22 0.05
FAS −1.2 −1.24 0.87
CAT −1.7 −3.51 0.018
TMTA (s) 62.4 81.33 0.47
TMTB (s) 148.3 114 0.32
CPRS- opp 60.76 66.83 0.43
CPRS-inatt 74.61 80.33 0.5
CPRS-hyper 68.53 70.16 0.83
CPRS-ADHD index 76.61 78.66 0.75
Significant P values in bold. ToL, Tower of London; DSF, direct number span; DSB,
span of inverse numbers; FAS, phonemic fluence; CAT, categorical fluency; CAT TMTA,
Trail-Making Test Part A; TMTB, Trail-Making Test Part B.
good agreement with previous reports (22), suggesting reduced
attentional orienting to warning stimuli in patients with ADHD
when compared to normal subjects. Indeed, reduced P300
amplitude has been interpreted as a failure to allocate sufficient
attentional resources to stimulus evaluation processes due to
reduced attentional capacity (23). On the other hand, although
the mean P300 amplitude of tscADHD patients was slightly
lower than that observed in healthy children, this difference
did not reach the statistical significance. These results might
be difficult to be interpreted, because we could expect that
tscADHD patients, expressing more severe ADHD symptoms,
could present more significant abnormalities. However, it is
important to note that, although most of literature data suggest
that children with ADHD show lower P300 amplitudes, there
are some conflicting results failing to replicate these findings
(24). Furthermore, in our sample of iADHD children, the
P300 amplitude showed a linear correlation with the cognitive
level, which was not found in subjects with TSC. Our results
therefore highlight that, although ERPs are a very interesting
technique to study brain functioning in neuropsychological
dysfunctions, P300 amplitude might be influenced by different
variables, especially by cognitive factors (20), which prevent
it to be used as a reliable marker of attention at least
in some neurological conditions. Although this cannot be
proven, we hypothesize that the marked network dysregulation
typical of children with TSC might be responsible of this
lack of association and that in such a brain disease P300
amplitude might not be a real marker of attention processes.
In addition, in the interpretation of these data, we cannot
exclude that results might have been influenced by patients’
age. Indeed, a longitudinal study showed that after the first
decade of life up to young adulthood, the P300 difference
between ADHD and non-ADHD groups is no longer significant
(25). Seen in this light, we must underline that in our
sample tscADHD patients presented a higher mean age, with
only two patients younger than 10 years, as compared to
FIGURE 2 | The figure shows the positive correlation (left) between P300 amplitude and total IQ score in iADHD patients (R2 = 0.35, P = 0.03). No significant
correlation (right) between P300 amplitude and total IQ score was found in tcsADHD patients (R2 = 0.004, P = 0.9).
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iADHD patients, who included 7 of 13 subjects younger
than 10 years.
MMN in ADHD
As for MMN, patients with ADHD (both with and without
TSC) presented statistically significantly higher amplitudes and
lower latencies, without differences between children with and
without TSC. It is to be underlined that the shorter MMN
latency in ADHD patients could not be attributed to a peripheral
event, because both the N1 and P2 latencies were not different
between our groups (iADHD and tscADHD patients and
healthy subjects). Although most of literature data suggest
that children with ADHD present a lower MMN amplitude
and an increased MMN latency (9, 18), there are also studies
revealing no significant differences (19)or an increased MMN
amplitude in ADHD (26). Furthermore, similarly to what
has been reported for P300, also the differences in MMN
amplitude between children with ADHD and HCs tend to
decrease with age (27). Whatever the reason of the disagreement
between the present results and those of previous studies, it
is conceivable that in patients with ADHD, who hardly keep
their attention focused on one target and are easily distracted
by unexpected stimuli, the MMN component shows shorter
latency and higher amplitude than in HC. Mismatch negativity
component is thought to reflect the preattentive detection of
deviants (28). Despite MMN is mainly generated within the
bilateral temporal cortex, it was shown that a further frontal
source is activated when the preattentive processing of deviants
is made difficult by a concomitant highly demanding task (29).
This frontal contribution to the MMN building can result
in a higher late MMN amplitude (29). Seen in this light,
the hypothesis can be made that in ADHD patients, whose
attentional resources are lower than in HC, even a simple
task (reading a novel), as that used in the present study,
can lead to the same result as a task requiring a far larger
attentional load.
Although P300 amplitude differentiated iADHD from
tscADHD patients, it is to be underlined that the MMN behavior
was similar in both groups of patients. Indeed, both iADHD
and tscADHD patients showed an MMN component shorter
in latency and higher in amplitude as compared to HC. This
finding can be relevant for two main reasons. First, from a
clinical point of view, it suggests that the MMN characteristics
are more dependent on the brain dynamics typical of ADHD
rather than on ADHD etiology. This means that in the
neurophysiological assessment and follow-up of ADHD patients
MMN can provide particularly useful information. Second,
the pathophysiological mechanisms of ADHD, which are far
to be completely understood (30), involve the brain circuits
subtending the involuntary attention, whose neurophysiological
marker is represented by MMN.
Limitations of the Study
This study has some limitations that must be considered. First,
we are aware that the sample studied is limited, but TSC
is a rare disease, with a very high range of neuropsychiatric
comorbidities; therefore, finding a homogenous sample of
patients in a specific age range has been quite difficult.
Furthermore, all patients with tscADHD presented structural
brain lesions in both the gray and white matter, and one
tscADHD patient was assuming an antiepileptic drug. We
cannot exclude that these elements can have influence the
ERP pattern in our tscAHDH patients. As for the typical TSC
brain lesions, a control population of subjects affected by TSC
but without presenting ADHD symptoms could have helped
us in disentangling the contribution of ADHD and that of
TSC to the observed findings. Future studies will be hopefully
addressed to clarify this issue. As for the single tscADHD
patient under antiepileptic treatment, it is to be underlined
that his exclusion from the statistical analysis did not change
our results.
Conclusions
While P300 amplitude is commonly considered a
neurophysiological marker of the efficiency of the attentional
processes, our data suggest that in specific clinical contexts,
such as TSC patients, the impairment of the cognitive
functions might not be reflected by reduced P300 amplitude.
This can occur when the cortical networks underlying
the attentional mechanisms are particularly disrupted, as
in TSC.
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